226 related articles for article (PubMed ID: 30295831)
1. Financial Conflicts of Interest in Inflammatory Bowel Disease Guidelines.
Grindal AW; Khan R; Scaffidi MA; Rumman A; Grover SC
Inflamm Bowel Dis; 2019 Mar; 25(4):642-645. PubMed ID: 30295831
[TBL] [Abstract][Full Text] [Related]
2. Reporting of financial conflicts of interest in clinical practice guidelines: a case study analysis of guidelines from the Canadian Medical Association Infobase.
Shnier A; Lexchin J; Romero M; Brown K
BMC Health Serv Res; 2016 Aug; 16(a):383. PubMed ID: 27528247
[TBL] [Abstract][Full Text] [Related]
3. Pharmaceutical company payments to dermatology Clinical Practice Guideline authors in Japan.
Murayama A; Ozaki A; Saito H; Sawano T; Shimada Y; Yamamoto K; Suzuki Y; Tanimoto T
PLoS One; 2020; 15(10):e0239610. PubMed ID: 33048952
[TBL] [Abstract][Full Text] [Related]
4. Financial Conflicts of Interest in Clinical Practice Guidelines: A Systematic Review.
Tabatabavakili S; Khan R; Scaffidi MA; Gimpaya N; Lightfoot D; Grover SC
Mayo Clin Proc Innov Qual Outcomes; 2021 Apr; 5(2):466-475. PubMed ID: 33997642
[TBL] [Abstract][Full Text] [Related]
5. Evaluation of Pharmaceutical Company Payments and Conflict of Interest Disclosures Among Oncology Clinical Practice Guideline Authors in Japan.
Saito H; Ozaki A; Sawano T; Shimada Y; Tanimoto T
JAMA Netw Open; 2019 Apr; 2(4):e192834. PubMed ID: 31026027
[TBL] [Abstract][Full Text] [Related]
6. Evaluation of Industry Relationships Among Authors of Otolaryngology Clinical Practice Guidelines.
Horn J; Checketts JX; Jawhar O; Vassar M
JAMA Otolaryngol Head Neck Surg; 2018 Mar; 144(3):194-201. PubMed ID: 29270633
[TBL] [Abstract][Full Text] [Related]
7. Undisclosed payments by pharmaceutical and medical device manufacturers to authors of endoscopy guidelines in the United States.
Bansal R; Khan R; Scaffidi MA; Gimpaya N; Genis S; Bukhari A; Dhillon J; Dao K; Bonneau C; Grover SC
Gastrointest Endosc; 2020 Feb; 91(2):266-273. PubMed ID: 31738925
[TBL] [Abstract][Full Text] [Related]
8. Financial conflicts of interest among National Comprehensive Cancer Network clinical practice guideline panelists in 2019.
Desai AP; Chengappa M; Go RS; Poonacha TK
Cancer; 2020 Aug; 126(16):3742-3749. PubMed ID: 32497271
[TBL] [Abstract][Full Text] [Related]
9. Undisclosed payments by pharmaceutical manufacturers to authors of inflammatory bowel disease guidelines in the United States.
Al Sulais E; Alsahafi M; AlAmeel T
Saudi J Gastroenterol; 2021; 27(6):342-347. PubMed ID: 34755712
[TBL] [Abstract][Full Text] [Related]
10. Industry compensation and self-reported financial conflicts of interest among authors of highly cited peripheral artery disease studies.
Bellomo TR; Hwang C; Spector-Bagdady K; Stanley JC; Corriere MA
J Vasc Surg; 2020 Aug; 72(2):673-684. PubMed ID: 31980241
[TBL] [Abstract][Full Text] [Related]
11. Financial relationships with industry among guideline authors for the management of acute ischemic stroke.
Niforatos JD; Pescatore RM
Am J Emerg Med; 2019 May; 37(5):921-923. PubMed ID: 30704949
[TBL] [Abstract][Full Text] [Related]
12. Financial Conflicts of Interest Among Authors of Clinical Practice Guidelines for Routine Screening Mammography.
Combs T; Tritz D; Ivy H; von Borstel D; Horn J; Vassar M
J Am Coll Radiol; 2019 Nov; 16(11):1598-1603. PubMed ID: 31152689
[TBL] [Abstract][Full Text] [Related]
13. Reporting of financial conflicts of interest by Canadian clinical practice guideline producers: a descriptive study.
Elder K; Turner KA; Cosgrove L; Lexchin J; Shnier A; Moore A; Straus S; Thombs BD
CMAJ; 2020 Jun; 192(23):E617-E625. PubMed ID: 32538799
[TBL] [Abstract][Full Text] [Related]
14. Evaluating Industry Payments Among Dermatology Clinical Practice Guidelines Authors.
Checketts JX; Sims MT; Vassar M
JAMA Dermatol; 2017 Dec; 153(12):1229-1235. PubMed ID: 29049553
[TBL] [Abstract][Full Text] [Related]
15. Evaluation of Financial Conflicts of Interest Among Physician-Authors of American College of Rheumatology Clinical Practice Guidelines.
Wayant C; Walters C; Zaaza Z; Gilstrap C; Combs T; Crow H; Vassar M
Arthritis Rheumatol; 2020 Sep; 72(9):1427-1434. PubMed ID: 32039569
[TBL] [Abstract][Full Text] [Related]
16. Transparency ethics in practice: Revisiting financial conflicts of interest disclosure forms in clinical practice guidelines.
Lu Y; Jones DJ; Sharara N; Kaltenbach T; Laine L; McQuaid K; Soetikno R; Subramanian V; Barkun A
PLoS One; 2017; 12(8):e0182856. PubMed ID: 28841650
[TBL] [Abstract][Full Text] [Related]
17. Authors of clinical trials seldom reported details when declaring their individual and institutional financial conflicts of interest: a cross-sectional survey.
Hakoum MB; Noureldine H; Habib JR; Abou-Jaoude EA; Raslan R; Jouni N; Hasbani DJ; Lopes LC; Guyatt G; Akl EA
J Clin Epidemiol; 2020 Nov; 127():49-58. PubMed ID: 32512186
[TBL] [Abstract][Full Text] [Related]
18. Relationships between authors of clinical practice guidelines and the pharmaceutical industry.
Choudhry NK; Stelfox HT; Detsky AS
JAMA; 2002 Feb; 287(5):612-7. PubMed ID: 11829700
[TBL] [Abstract][Full Text] [Related]
19. Evaluation of financial conflicts of interest and quality of evidence in Japanese gastroenterology clinical practice guidelines.
Murayama A; Kamamoto S; Murata N; Yamasaki R; Yamada K; Yamashita E; Saito H; Tanimoto T; Ozaki A
J Gastroenterol Hepatol; 2023 Apr; 38(4):565-573. PubMed ID: 36518089
[TBL] [Abstract][Full Text] [Related]
20. Conflict of interest reporting in otolaryngology clinical practice guidelines.
Sun GH
Otolaryngol Head Neck Surg; 2013 Aug; 149(2):187-91. PubMed ID: 23702973
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
